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U ncermmry regarding potential disciplinary action may give phy~ician~ pause when considering whether to accept a chronic pain patient or how ro treat a p.I-
tiem who may require long-term or high doses of opioids. 
Surveys h..we 'ihown that physicians fear potential disciplin-
ary action for prescribing controlled substances and thar 
physicians wi ll , in some cases, inadequately prescribe opio-
ids due to fear of regulatory scrutiny. Prescribing opioids for 
long-term pain management, particularly noncancer pain 
management, has been comroversial; and boards have inve~­
tigated ~md, in some cases, disciplined physicians for such 
prescribing. While in virruallr all of these cases the disci-
plinary action\ were successful!) appealed, news of the success 
wa.., nor often as well-publicized as news of the disciplinar} 
acnons, le~wing wme physicians confused about their poten-
tialliabilif} when prescribing opioids for pain. The confusion 
has perhaps increased as a re ult of two relatively recenr 
cases, one where a physician w<U>succcssfully disciplined by 
~1 stare medical board for undcrrream1cnt of his patient'>' pain, 
and anorher where the physictan was successfully o;ued for 
inadequate pain treatment. 
In the first case, in September J 999, the Oregon Medi-
cal 13oard disciplined a physician for failun: to adequately 
n·eat ~cvcral of hi~ pariems for pain. Less than two year~ 
later, a California physician \Va'> successfully sued for hi.., 
undertrearmenr of a patient's pain. These cases reflect a chang-
ing attitude toward pai n treatment in the United States-a 
recognition that pariems, especially patients ar the end of 
life, have a right to adequate pain treatment. This shift in 
thinking appear'> to have begun in the late 1980s. Prior ro 
this time, "according to established medical opinion, the 
likelihood of ,1ddiction w opioids was considered too great 
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ro prescribe them to any patients bur tho c uffcring from the 
most serious pain."1 This opinion was conveyed by anum-
ber of state medical boards to physicians who were disciplined 
for prescribing ourside of these boundaries. The ·'sea change" 
came about "a evidence moumed that patients, especially 
cancer patients, were being underrreated for their pain, and 
that addiction was not a signi ficanr problem for puin patients 
with no prior history of substance abuse. "2 ln re ponse, phy-
..,icians hegan ro prescribe greater amounts of pain medication. 
In addition, professional and governmental agencies estab-
lished clinical guidelines encouraging the appropriate use of 
opioids in the treatment of cancer pain. Many stare legisla-
mres al~o passed "intractable pain tamtes." These law "were 
designed ro provide physicians with some assurance~> by re-
ducing both the real and perceived risks of being subjected ro 
regulatory anctions for treating pain with controlled sub-
'>tances."' 
Yet, ar the same time that these new legal pressures would 
<,cem to counteract rhe pressures to underrrcat, a renewed 
concern about drug diversion, in light of the abuse associ-
ated with OxyContin, has taken shape. Evidence of diver ion 
of the medication from legitimate users ro addict'> has caught 
the attention of drug and law enforcement agencies that have 
linked OxyConrin to overdose deaths, pharmacy robberies, 
and other criminal activities related to obraining rhc drug. 
This rurn of events has the potential for rekindling the atten-
tion of state medical boards and law enforcement agencies 
toward ph)'Sician prescribing practices for patienrs suffering 
from pain. 
In an effort to better tmdersmnd how state medical boards 
are evaluating and balancing the need for adequate pain treat-
ment with concerns about drug diver ion and inappropriate 
prescribing, we undertook a survey of <,tate medical boards 
across the country. This article, after briefl)' describing the 
evolution of medical knowledge regarding the treatment of 
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pain, the history of efforrs to regulate controlled substances 
used to treat pain, and the Literature regarding physician con-
cerns about legal repercussions for prescribing opioids, 
reports on the results of the survey. 
We conclude that boards have made improvements in 
the way they approach physicians who prescribe large doses 
of opioids. Greater reliance on pain policies has given many 
boards clearer criteria for when to investigate and discipline 
physicians for opioid prescribing violations. The observed 
improvements involve recognition by most boards that phy-
sicians have an obligation to provide adequate pain 
management to their patients. This recognition has required 
boards to balance their concerns about opioid overprescrib-
ing with their concerns about pain undertreatment. We found, 
however, that boards appear to be more concerned with vio-
lation of standard of care in cases of overtreatmem versus 
undemeatment. Respondents (spealcing on behalf of their 
boards) viewed opioid overprescribing as a dear violation of 
standard of care and a clear example of patient harm, whereas 
pain undertrea011ent- particularly for nonmalignant chronic 
pain -was not so clearly perceived as a standard of care 
violation, <md generally required a higher threshold of hann. 
We conclude that the boards are still trying to find the right 
balance berween promoting adequate pain management and 
protecting against opioid diversion and abuse. 
THE EvoLUTION OF TREATING P AlN WITH Ortoms 
Progress in pain management has evolved over the last few 
demdes. Beginning with the hospice movement i.n the 1960s, 
and continuing beyond the 1994 guidelines for the manage-
ment of cancer pain published by the Agency for Health 
Care Policy & Research, opioids (in combination with other 
medications) have been idenri fied as the standard treatment 
for moderate to severe cancer pain. In addition, opioid 
therapy has been shown to be effective for patients with cer-
tain types of chronic nonmalignant pain, without the 
occurrence of intolerable side-effects or the development of 
aberrant drug-related behaviors.4 Its use in patients with 
malignant and nonmalignant pain bas been shown to im-
prove functional status a11d quality of life. 1 Moreover, the 
consensus among addiction specialistS is that substance abuse 
history per se does not preclude the use of opioids for pain 
management, bur it does mandate careful assessment and 
monitoring of such patients by a trained pain specialist.6 
At the same time thar these pain management treatment 
standards have evolved, there have been ongoing efforts to 
regulate the prescribing of opioids. These efforts began with 
the passage in 1970 of the ControUed Substances Act and the 
establishment in 1973 of the Drug Enforcement Agency (D EA). 
At the federal level, the ConrroUed Substances Act and the 
DEA make up the main armarnents in the government's ef-
fortS ro prevent drug abuse. At rhe state level, there are 
comparable laws as well as state drug cnforcemenr agencies 
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and bureaus of narcotics control. Since the 1970s, the 
government's attitude has shifted in focus, particularly after 
Presidenr Reagan rook office, from viewing drug abuse as a 
public health problem ro viewing it as a political, law en-
forcement, and moral issue? Although the DEA and other 
federal laws and policies rend to be less restrictive of physi-
cian practices than state laws and enforcement practices, 
concerns about Medimre and Medicaid fraud and abuse and 
the government's "war on drugs" have put pressure on state 
medi.cal boards.8 This has resulted in some state boards dis-
ciplining physicians for "overprescribing" opioids, including 
physicians who were treating pain patients.9 Thus, in addi-
tion to fears that patients will become addicted, 10 and that 
doses of opioids that are roo high will lead to patient deaths, 11 
physicians avoid prescribing opioids because they believe 
they may face legal or regularory sanctions or simply be the 
target of investigation by licensing boards or other law en-
forcement agencies. 12 However, research has hown that 
physicians' fears of legal or regulatory sanctions are more 
the result of a "chilling effect" than of the actual risk of 
disciplinary or legal liability they face if they properly pre-
scribe opioids for pain management. 11 
Several physician surveys have provided evidence of the 
chilling effect of sanctions against physicians for opioid pre-
scribing. ln 1990, physician members of the Eastern 
Cooperative Oncology Group were surveyed and 18 percent 
of 897 responding oncologists rated excessive regulation of 
analgesics as one of the top four barriers to adequate cancer 
pain management.'4 Ln a 199 L survey of members of the 
American Pain Society, 40 percent of surveyed physician 
members said concerns about regulatory scrutiny rather than 
medical reasons led them ro avoid prescribing opioids for 
chronic noncancer pain patients . .. 1 [n a survey of Wisconsin 
physicians c011ducted in the same year, over half reported 
decreasing the dose, quantit)) or number of refills, or switch-
ing to a lower scheduled medication, due to fear of regulatory 
scruriny. 1" And, in a I 993 California survey, 69 percent of 
physician respondents felt that doctors were more conserva-
tive in their use of opioids in pain management because of 
fear of disciplinary action, and a third felt that their own 
patients may be suffering from untreated pain. 17 
ln an effort ro better understand stare medical board 
members' knowledge and attitudes toward physician pre-
scribing of opioids for pain management, the University of 
Wisconsin Pain & Policy Studies Group (PPSG) conducted a 
survey of members of state medical boards in 1991. J oranson 
and colleagues found that ·' [w]hile most respondents agreed 
that the prescribing of opioids for the cancer patient was 
legal and generally acceptable medical practice, only 12% 
were confident in the legality of prescribing for the patient 
with chronic non-cancer pain; the majority of respondentS 
(77%) would discourage this practice or even investigate it 
as a violation of the law." 18 They also found that board mem-
bers responding to the survey had a lack of knowledge about 
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cancer pain management and the meaning ami incidl!ncc of 
addiction when opioids are used to manage pain. In 1997, 
the PPSG (which conducted worlc.hop!> berwecn 1994 and 
1998 w educate board member!. around the counrry nbout 
pam management i!>!.ues) repeated the survey and found some 
improvements in nttirudes of medical board members. Spe-
cifically: 
• rcspondcnrs were more likd) in 1997 than in 
1991 to recognize that opioids are undemtilizcd 
as annlgesic<> for cancer pain; 
• respondems in both survey~ ovl!n~!.tinwted the 
incidence of addiction ro pain medications, bur 
in 1997 fewer respondents confused addiction 
with physical dependence; and 
• medical board members in 199 Land 1997 \\ere 
more skeptical about prescribing opioids for 
noncanccr than for cancer pain, bur respondentS 
in 1997 were more likely to consider prescrib-
ing opioids to patientS wirh chronic noncancer 
pain for more than several months a::. acccprablc 
medical practice. 1'' 
Since 1997 there have been a number of changes in the 
legallandsc::~pe rc~arding the prescribing of opioids for pain. 
Recently there has been an increased focus on undertreannenr 
of pain, influenced in parr by the increased ::~ttention given ro 
palliative ::~nd end-of-life care and the conrrover~y surround-
ing physician-as~i~rcd suicide. The American Society of Law, 
Medicine & Ethics (ASLME), with support from rhc May-
day Fund,l11 has addressed the issue of pain underm:anncnt 
through a variety of educational initiatives and projects. In 
1998, A~LME\ joint work with the Federation of Sratc 
Medical Boards (fSMB) resulted in 1998 in the J\1odcl Guide-
lines for the Use of Controlled Substances for tht: Treatment 
of Pain, rhus giving clear guidance to state medical hoard~ 
regarding opioid use for chronic pain. 21 The PPSG hao; been 
rrackmg rhe adoption of the Model Guidelines as well as 
orher state pain policies more generally for over a decade. 
From 1989 to 200 I, there was a dramatic increase in the 
number of new state pain policies adopted by stare boards 
and legislatures. Many state boards have adopted policic~ 
that arc consistent with the FSM B's Model Guidelines (e.g., 
endorsement of a balance between preventing opioid misuse 
and nor interfering with appropriate opioid prescribing; en-
dor::.emenr of multidisciplinary collaboration in treating p:1in 
patient..,~ inclu:.ion of treatment standards for chronic non-
malignant pain as we ll as standards for acute and 
cancer-related pain).u HoweYer, there is no ltterarure indi-
cating how state boards ::tre applying the guidelines and 
Y\ herher they ::~re implementmg balanced policies for the 
man::~gement of both m::~lignant and norunalignanr pain. 
In addition ro the efforts of rhe ASLME, PPSG, and 
FSMB, groups like Compassion in Dying have been trying ro 
counter the chilling effect of sanctions for opioid pre::.cribing 
by drawmg attention to cases in which pain was undertreated. 
2J 
In 1999, the Oregon Medical Board was the first in rhc na-
tion ro discipline a physician for failure ro pre cribe adequate 
pain relief medication. The physician, Dr. Paul Bilder, was 
cited for several pain undenrearmenr infractions, including 
prescribing insufficient pain medication for a terminally ill 
cancer patient (i.e., only Tylenol) and prescribing only a frac-
tion of rhe dose of morphine that another patient needed and 
the hospice nurse suggested. Dr. Bilder wa~ ordered by the 
medical board to complete an educational program on phy-
sician-p::~ricnt communication and undergo mental health 
rrearment.11 In anorher case, in June 200 J, a California jury 
awarded 1.5 million dollars to the surviving children of Wil-
liam Bergman, whose children sued their father's physician, 
Dr. Wing Chin, for undertreating Mr. Bergman'~ cancer pain 
before he died. Although the award was !>ub~equenrly re-
duced by the court, it was a dramatic message to physicians. 
Moreover, in the same year, drug enforcement officials from 
the DEA and twenty-one health organizations issued a joint 
statement that they had begun to work together "to prevent 
abuse of prescription pain medications while ensuring that 
they remain available for patients in need. "14 
Almost at the same time that we experienced this shift 
in focus toward concern~ about underrreatment of pain, a 
new risk surfaced that threatens rhe balance of providing 
effective pain relief while minimizing abuse and diversion of 
opioids- the abi.ISe of OxyContin. OxyConrin was approved 
by the Food and Drug Administration in 1995. It has fewer 
side-effectS than morphine but works similarly. It contains 
oxycodone in a time-released formu lation that works over 
12 hours, m::tking ir ideal for sufferers of both malignant and 
nonmalignant chronic pain. However, abuse of the drug be-
gan when it was discovered that crushing the tablet and either 
snorting ir or mixing it with water and injecting ir produced 
a potenr high. Thus, OxyConrin has high addictive potential 
for drug abusers and a high street value. According to the 
DEA Office of Diversion Conrrol, from 1996 to 1999 the 
number of drug abuse deaths reported to the Drug Abuse 
Warning Network (DAWN) that involved oxycodone more 
than quadrupled, with 268 deaths in J 999 compared to 5 I 
in 1996.25 Several cases were reported in the medi:1 stating 
that physicians who prescribed OxyContin in relatively high 
doses were disciplined by their stare medical boards. l~ 
SURVEY OF STATE M EDICAL B OARDS 
In order to better understand how smte medical board!> are 
balancing concerns about physicians underrreating pain with 
concerns about phr::.icians overprescribing opioids, we un-
dertook a nationwide survey of state medical boards. More 
~pecifically, the sn1dy sought information regarding trends in 
the number and nature of complaint!:> received by boards for 
inappropriate prescribing of opioids (i.e., "overprescribing" 
or "underprescribing"), how boards evaluate such complaints, 
and under what circumstances bo::~rds would discipline phy-
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sicians falling into one of tho e categories. The focus of the 
survey was board experience during the lastS years (1997-
2001 ). The survey was conducted in Late 2001 and the first 
half of 2002, just after the high visibility given ro the abuse of 
OxyConrin in the press. 
METHODS 
As a first step, we developed a telephone survey tool basetl 
on available literarure and input from experts in the field of 
pain research and state medical board staff to identify state 
medical board practices related to prescribing of opioids for 
the treatment of pa.in.H Survey questions included the narure 
of complaintS the board received over the previous 5 years 
regarding opioid overprescribing and subsequent investiga-
tions of physicians and disciplinary action taken; the narure 
of complaintS the board received regarding undertream1ent 
of pain by a physician; the board's use of a pain management 
expert in cases involving opioid prescribing; the likelihood 
of the board raking disciplinary action against a physician for 
underrreatment of pain; and the board's educational activi-
ties directed to physicians regarding treatment of patients 
with pain. The srudy was approved by a University of Mary-
land institutional review board. 
The survey was directed (by name) to the state board 
medical director, or individual with a comparable title, and 
that individual was asked to participate in the survey or to 
provide the name of someone else in the agency who would 
be most able to answer the survey questions. Of the fifty 
stares and the District of Columbia, thirty-eight tate medi-
cal boards participated (a 74.5 percent response rate). 
Seventeen respondents were state medical board directors, 
ten were chief investigators or prosecutors, and the remain-
ing eleven included individuals with the following titles: 
"medical director," "medical consultant," "program admin-
istrator," "senior complaint analyst," "chief [or 'director'l of 
compliance," "consumer assistant," and "director of com-
plaints and allegations." The respondents' average number 
of years in their current position was 6.0 (standard deviation 
= 5. 7). Ten respondents were physicians, seven were law-
yers, three were nurses, two were social workers, and several 
had o ther advanced degrees (e.g., in business, public admin-
istration, and public health). Ten had worked in a similar 
capacity before working in their current position. Thirty-
four respondents completed the survey by phone, and four 
completed the survey in written form.u Qualitative com-
mentS were transcribed directly from phone conversations 
or from written commentS on faxed or mailed-in surveys. 
Boards of those who responded differed in two signifi-
cant respectS from those who did not. First, respondentS were 
more likely not to have regulations, guidelines, statutes, or 
policies regarding opioid prescribing than nonrespondenrs. 
lnrerestingly, all of the boards without such regulations, guide-
lines, statutes, or policies participated.29 Second, respondents 
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were more likely than nonrespondenrs to have implemented 
an electronic prescription monitoring program that provides 
access to a database of physicians' prescribing and pharma-
cistS' dispensing practices from pharmacies in the state. A 
total of sixteen states have currently implemented a prescrip-
tion monitoring program, all of which are electronic.30 
Thirteen of those sixteen states responded to the survey. 
REsULTS 
Opioid overprescribing: CompJaints 
Respondents were asked to estimate the number of com-
plaints31 their board had received in 200 J related to opioid 
overprescribing (i.e., "physicians who allegedly prescribed 
opioids unnecessarily, in roo high a dose, or for too long a 
duration")Y· An estimate was requested because most boards 
do not formally categorize complaintS that relate specifically 
to opioid overprescribing. J.l 
1\venty-five respondentS were able to estimate the num-
ber of opioid overprescribing complaintS in 2001. According 
to those estimates, the average number of complaints was 
3.1 per 1,000 doctors in the state (standard deviation= 2.8, 
range = 0 to 13.8).34 The most common sources of these 
complaintS were pharmacies, government regulatory agen-
cies such as the DBA, and family members of patients. Other 
sources included physicians, law enforcement agents, or the 
board itself (i.e., in the course of another investigation, the 
board may have discovered cases of suspected opioid over-
prescribing). Some qualifying comments regarding the 
number of complaints included: "some [complaints] run 
together, for example, a complaint about sexual involve-
ment may overlap with [a complaint abour] opioid 
overprescribing," and "we do not track it that way, but my 
sense is, it's extremely small. Out of 700 complaintS ... un-
der a dozen rend to be related to [opioid overpre cribing, 
mostly criminal referral]." 
Eleven respondents were not able to estimate the num-
ber of opioid overprescribing complaintS their board received 
in 2001 and shared comments such as: "we don't keep that 
type of information .... [W]e categorize drug diversion, in-
competence, negligence .... r really don ' t know"; "I know 
the number of complaints for inappropriate prescribing, 
bur I don't know how many of those were for opioid over-
prescribing"; and "1 couldn't give a fair estimate, we have 
codes within our rrackingsysrem, bur a lot of time the track-
ing code we put in isn't the same as the order to show cause 
or the fmal adjudication." In this regard, one respondent 
reported thar his board was "getting ready to add 
undemearment of pain ro the [complaint form) as a specific 
cause." 
When respondents were asked their impression of 
whether complaints against physicians for opioid overpre-
scribing had increased, decreased, or stayed the same in the 
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Complaints 14 
(37%) 
Investigations 15 
(39.5* ) 
Disciplinary Actions 14 
(37%) 
past 5 years, !>eventeen respondents (44 .5 percent) thought 
com plaints had stayed the -amc ("on average there's a rela-
tively ftxed population of drug- ceking patientS and a relatively 
constant population of providers willing ro prescribe"), four-
teen (37 percenr) thought they had increa ed, four (J 0.5 
percent) thought th(!y had decreased, and three did nor know 
( ee Thble I). 
Drug diversion and abuse trends: OxyContin 
Respondents were asked whether the problem of drug diver-
sion and abuse in their state, in general, had improved, become 
worse, or stayed the ame in the last 5 years. Eighteen (47 
percent) thought it had become worse, eleven (29 percenr) 
thought it had stayed rhe same, and five ( 13 percent) thought 
it had improved. Four had no real impre sion. Some com-
mented that the drug diver ion/abuse problem wa nor 
necessaril y worse, but the board was doing mo re ("raking a 
little sterner approach rhan before 1996"; "pursuing it more 
d iligently; we're more on top of it now"; and "we have more 
ophisric.c'lted investigarory techniques, so we may just be more 
aware of what's going on"). Fifteen of the eighteen who 
thought d rug diversion and abuse in thei r . tate had become 
wor e (83 percent) thought that the abuse and diversion of 
OxyContin had contributed to that trend, while the remain-
ing three thought it had not. Some identified the problem!> 
with OxyConti n as prompting newly enacted legislation es-
tablishing a prescript ion monitoring program in the state. 
One respondent commented : 
Any time you have a drug that has as much pre s 
as [OxyConrinJ, it identifies weaknesses in :.ystems. 
Then you have people who are more wil~ ng to look 
for new ways to identify diversion and abu e. This 
might be one aspect that plays into the desire of 
some to have this new drug moni toringsy rem ... 
[to find] mechanisms to identify if a patient had 
been to other physiciam, [looking for drugs to feed 
an addiction], o r indications of [JrugJ diversion/ 
abuse, for peace of mind of the physician. 
DEcREAsm STAvmnmSAME No OPINION 
~ 
4 17 3 
(10.5%) (-14.5%) (8%) 
3 17 3 
(8%) (-14.5%) (8%) 
6 IS 3 
( 16%) (39.5%) (8% ) 
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Another stated: "an electtonic database system would be ideal. 
It work both ways: If a doctor wonder!> if he's the sixth doc 
in the pathway, he can call the board and get the answer in a 
few minutes, and [vice versal." 
Some respondents thought the abuse of OxyConrin had 
made the public more aware of diversion issue ·, but had 
"not increased [their] complaims or investigations." Others 
made reference to OxyContin's being "the drug of the month" 
("20 years ago it was Dilaudid, then Percocet, once upon a 
time it wa · Demerol"; "OxyComin is a new problem, but 
Lortab is more abused; there's still a diverse array of drug "; 
"0 yContin is just another drug in the mix"). One respon-
dent commented: "we don't have issues with physicians 
abusing OxyContin .... roJur problem has been with patients 
elling o r diverting the OxyContin and physicians not tuning 
in to thar." A few respondent , however, described !>erious 
problems in their state with overdo e deaths from OxyContin, 
o r of people in their tate breaking into pharmacies and hold-
ing pharmacists up at gunpoint, specifically reque ring 
OxyContin ("we have seen a tremendous problem of crimi-
na l theft o f OxyContin"). One respondent de cribed local 
police and health care providers with an "otherwise unblem-
i hed record for 20 years ... getting addicted to OxyConrin 
.. . [and] stealing from patient." Others reported increased 
prescriptions of OxyConrin, bur a one respondent com-
mented : " that's not proof of d iversion." 
Investigations for overprescribing 
When asked whether their board had changed its approach 
ro investigating physicians for opioid pre cribing in re ponse 
to OxyContin abuse and d iversion, twenty-nine (76 percent) 
aid no and five (13 percent) said yes. Four had no opinion. 
Those who had nor changed their approach commented that 
they conducted the ''same thorough investigation" of all valid 
complaints. Others felt their investigative approach had not 
changed, but their attention to the issue had increased. One 
respondent identified drug diversion as a p1ioriry of the board, 
which was working more with law enforcement to "stay on 
top of what' going on. " Another respondent explained that 
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the approach of their board included adapting to changes in 
drug-seeking and diversion behaviors over the years: 
[fhe] physician's comminee of the medical soci-
ety ... offers very consistent counsel; they've tight-
ened their procedures over the years because the 
screening tests we had in place for monitoring 
[opioidsJ needed to be beefed up. They found loop-
holes like ... "beat-the-piss-test.com" websites, 
[which led to requiring] all testing atone lab. We've 
gone back and identified a lot of problems. It's 
bener to nip it in the bud before it gets too out of 
control. 
Another respondent commented: 
It's just a change in the marketplace we've taken 
cognizance of. We just had a huge case of overpre-
scribing where in the testimony it became appar-
ent the number of patients looking for this kind of 
prescriber. This particular doc had people com-
ing from other states. That was his defense: "If 
someone is in pain, you give them drugs." But the 
board said, "Not necessarily. You comply with good 
medical practice; you assess them and follow up 
and keep records, etc. You don't just give them 
drugs." 
Respondents from other boards admined that finding the 
right balance between identifying physicians who overpre-
scribe opioids and those who are appropriately treating 
chronic pain is not ::dways easy. As one respondent stated: 
"[We're] still working on trying to figure out the appropriate 
balance between pain management and overprescribing. 
We're sti ll looking at research ro find that balance." 
When asked whether board investigations of physicians' 
opioid prescribing practices had increased, decreased, or 
stayed the same over the past 5 years ( 1997-2001 ), seventeen 
respondents (44.5 percent) said the number of investigations 
had stayed the same, fifteen (39.5 percent) said they had 
increased, three (8 percent) said they had decreased, and 
three did not know (see Table 1). Respondents were asked 
why they thought the number of investigations had increased 
or decreased. For those that answered increased, the most 
commonly cited reasons were increased "public awareness .... 
patients and families are more aware," and "people are more 
inclined ro speak up than they have been in the past." Some 
mentioned law enforcement actions ("there have been more 
cases where there have been convictions [of physiciansl on 
drug trafficking and selling lopioid] prescript:ions for money"). 
For those that answered decreased, one respondent cited 
economic factors that limited the resources the board could 
direct toward investigations. Changes in the board's arrin1de 
roward opioid prescribing was mentioned as a reason for 
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increru.ed and decreased investigations over the pru.t 5 years. 
One respondent shared his impression that "the board is 
taking these cases more seriously than in the past ... [by] 
cracking down on doctors who are overprescribing, and 
wanting us to find information to back that up." Another 
mentioned that physicians have clearer grounds for being inves-
ti~ted if they do notundersmnd the board's mles for the treaonent 
of chronic pain and are practicing outside of their specialty 
area. Others pointed to their board's changed attitude to-
ward the treatment of chronic pain and how this has resulted 
in fewer full investigations: "The board's arrin1de toward 
prescribing opioids has changed. lf a docror can provide docu-
mentation showing that [s]he's following pain management 
guidelines, the board doesn't pursue [itJ further." 
Respondents were asked what factors would determine 
whether their board \'I.'Ould fully investigate a physician for 
overprescribing opioids.ll A "full investigation" was defined 
as going beyond initial facrfinding (i.e., beyond merely send-
ing a lener of inquiry to a physician or reviewing pharmacy 
records). For example, one respondent explained that when-
ever his board received a complaint against a physician related 
to opioid prescribing, the board conducted a preliminary 
investigation during which it rypically requested a two-year 
profile from the state pharmacy board to look at the general 
prescribing practices of the physician. If rhey saw a pattern 
of inappropriate prescribing or had received "a series of com-
pbinrs over the years that poinr[ed] to there being a problem," 
this would trigger a full investigation. Six respondents stated 
that their boards fully investigate all complaints related to 
opioid overprescribing. 
State pain guidelines, starures, regulations, or policies 
were mentioned as providing guidance for when to proceed 
with a full investigation of a physician for overprescribing. 
All but six of rhe boards responding to the survey currently 
have some form of guideline (si'<teen), statute (fifteen), regu-
lation (twelve), or policy (nine) related to pain management. 36 
For many boards, if a complaint was made against a physi-
cian who wac; found nor to be in compliance with the board's 
pain rules/guidelines, rhis would trigger a full investigation 
of that physician. Comments included: "if we don't have 
good documentation, if it doesn't appear that the physician's 
following the board's guidelines with respecr to prescribing 
for pain, tl1en we'll investigate"; "for the most part we ad-
here to [our pain gujdelines] .... [we've made] a lot of progress 
... teaching physicians how to do this appropriately. We ser 
the minimum standard of care in any stare, documentation, 
informed consent, proper referral, etc., so we look for that"; 
and "rhe general policy that was made known to physician~ 
i!> that we leave prescribing and pain management control 
issues to their professional judgment, but if there is a com-
plaint, they better have proper documentation, such as 
informed consent, history and physical, monitoring, etc." 
Some respondenrs commented that the volume or 
amount of opioids prescribed by a physician might trigger an 
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inve~tigarion- for example, if there were "large numbers of 
patients receiving large number!> of opioids from the ~a me 
individual who was seeing patients from a large geographic 
region, that would rriggcr an investigation." Also, "if there were 
extremdy large dosage. !prescribed], dur would make [the boi.trd] 
question if the patient could safely consume that much.'' How-
ever, if there was evidence rhar backed up the need for the 
amount of opioids prescribed, most boards would not inve~­
tigare further (e.g., .. if we determined that d1ey were providing 
therapemic intervention , then we would close the investiga-
tion"). One respondent provided the following example: 
rf a person [has] had low back pain for the last 12 
)Cars and has been raking long-term increa~ing 
do~es of pain medicine over the year!>, and the 
family is reporting it because [their family mem-
ber is] an addict now, thar wou ld be investigated. 
Any allegation that the pain is not sufficient to 
warrant the prc~cribed opioid [would be investi-
gated], so if it\ a cancer patient, no one will argue 
with that. 
Another commented: 
If we get a complaint that a doc's prescribing 
Ox)rConrin 80 mg four times a day or three times 
a day, ,- we'll ask the plurmacist if it'~ a cancer 
patient. Sometimes the pharmacist doe~n 't know, 
bur ... if they tell w. it 's nor a cancer patient, it\ 
more than likely the doc will get investigated. 
Numbers are certain ly an indicator, but they're 
not the only indicator- ir's hard ro answer with 
a straightforward answer. Every ca!)e ha:. a differ-
ent rwisr to it. 
In the absence of a board pain nunagement policy or 
guideline, decision~ about investigating or disciplming a phy-
sician were often ba~ed on deviations from the recognized 
standard of care. For example, a respondent from a stare chat 
had contemplated but not yet adopted pain management guide-
linesstated: 
[An investigation is triggered byl the devianon from 
an .1ccepted norm - if ~omeone is prescribing 
differently from their peer~ in a specific spccialt). 
As an example, the pain management people will 
write I 0 time~ the amount of opioids as others. 
We wouldn 'r waste time with that person. Bur if a 
physician's billing as an inrerni~r and prescribing 
the -;a me as a pain management per<>on, we're go-
ing to go find our why. And if the pain manage-
ment person i!> pre~crihing way above or hers, we'd 
check that our roo. Deviations from a norm we 
observe, bur we don't est.1bl ish the norm. 
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Another commented: 
[We're] looking nt complaint~ and poor charting, 
[ca:.es where 1 the patient "lost the prescription" 
and the docror write~ another, bur there\ no docu-
mentation of diagnosis or follow-up, etc. The 
phy~ician 's probably gotten on lack of docu men-
tation- we can ' r prove fraud or diversion, bur 
we can prove good medical practice standa rd~ 
were not [maintained]. 
Several references were made rousing judgment in e3ch 
ca~e: 
You have to apply judgment; thi~ is not an area 
that lends itself ro cookbook approaches. You have 
to react to good intelligence, for example, a reli-
able source like a pharmacy or a.norher health care 
provider-their threshold to report to the board 
is high. We review DEA reportS for exce~., pur-
chases monitOred, but pure volume doesn't neces-
sa rily indicate a problem. You have to tell whetha 
it\ below standard of care, not jusr volume. 
In addition ro rhe volume of opioids prescribed, the 
credibility of rhe complai nt source, and whether there i~ 
documented compliance with the pain management <,tan-
dard of ca re, board po licies or guidel ine'>. or state 
regulations and statutes, boards look ar the egregiou!>ncc,s 
of rhe physician·~ conduct. One instance of highly egre-
giou::. co ndu ct may be sufficient to warrant a full 
investigation and subsequent discip line, wherea., with 
milder forms of physician misconduct, a board may look 
at the number of complaint::. and evaluate patterns of inap-
propriate prescribing or practice. The uniqueness of each 
Gl'>c wa~ emphasized by man) respondents. Comments in-
cluded: "each ca~e i., done on an ad hoc ba~i'>; ir depends 
on who is reporting, wh.u the allegations arc, how egre-
gtotts [the physician\ conduct was], the past hi'>tory of the 
doctor, etc.,. and "It's nor a simple answer; there\ no quota 
sy~rem that a speci fie amount of drug means you're ri pe 
for investigation. We're looking ,u .1number of aggravat-
ing factors." 
In <,Ome scares, medical hoard invc.'>tigarors worked 
closely with law enforcement, and thu!> looked closely at the 
quality of evidence collected against a phy~ici ;ln (e.g., wit-
ness testimony qualiry, corroborating e\~dencc- for example, 
if anyone observed the physician improperly prescribing opio-
id., - ho~piral records). One re'>pondcnr o;tatcd: "p.1rrnership 
with bw enforcement is a very productive way to run an 
investigation. They're more expert on the criminal.,ide, more 
able to tdenrify witnesses - like people \\ ho get sex for 
drugs don't want to testify, bur police have v. ays to find will-
ing victims to come forward." 
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Discipjjoe for overprescribing 
When asked whether respondents thought the number of 
physicians in their state who had been disciplined for over-
prescribing opioids had increased, decreased, or stayed the 
same in the past 5 years, fifteen (39.5 percent) thought the 
number had stayed the same, fourteen (37 percent) thought 
it had increased, six ( 1 6 percent) thought it had decreased, 
and three had no real impression (see Table I). Reasons 
given by those who thought the number had increased 
included an increase in numbers across the board ("our gen-
eral numbers have increased" and "everything's gone up; 
discipline for prescribing violations has not increased more 
as [a] percentage of the total, we're clearing [backlogged cases] 
more quickly, we streamlined our processes"); increased 
awareness ("it has to do with increased public awareness, 
increased awareness on our part; OxyConrin is more real-
ized by all of us," and "there's generally a greater awareness 
in the professional community and the public about this is-
sue now"); an increased level of sophistication amoug drug 
diverters/abusers ("people arc more sophisticated about get-
ting drugs"); and increased scrutiny by the medical board ("I 
think we're more aggressive in taking action because the 
information is available to the doctors about proper pre-
scribing practices"; " I would think it's ... increased due to 
increased vigilance. Members of the board are on the look-
out for that"; and "the board is paying more attention to 
these issues, investigating them more seriously, that's my 
impression"). 
Reasons given by those who thought the number of phy-
sicians disciplined for overprescribing had decreased over 
the past 5 years involved the redefinition of "overprescrib-
ing." Respondents explained: "the board's attitude has 
changed; now we have pain management guidelines and have 
an established way of determining if a physician is deviating 
from those guidelines. We're more aware of the need for 
adequate pain management and how that should be docu-
mented"; "Because the quantity of opioids thought to be 
appropriate has increased tremendously, those who used to 
be disciplined now are not considered in violation. The up-
per limit has been raised, and we're okaying quantities now 
I that are] four ro six times greater than before"; and " I think 
we were more restrictive than we are now. Now we recog-
nize the necessity for pain management. ... [There's] increased 
vigilance bur an acknowledgment that pain managemenr is 
nccessory. We have a policy and pain management guidelines 
now." Another respondent described a move by the board 
toward a more proactive approach that averts the need for 
disciplinary action: 
[W]e utilize other types of informal processes to 
try to address a [physician] before a pattern of bad 
practice is established .... [W)e identify (a physi-
cian who] . .. needs further education but hasn't 
established the [bad] pattern or egregious conduct 
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-we move some of those through [a special pro-
gram that is proactive rather than reactive]. 
Onere pondcnt identified being more proactive with opioid 
prescribing issues as a goal that his board was moving to-
ward: '']don't think the board has been looked at as being 
proactive; they've been seen as more reactive, so we're try-
ing to change that. [t's hard, though." 
Respondents were asked whar facrors would determine 
whether their board would discipline a physician for over-
prescribing opioids. Several respondents commented that each 
case has a unique combination and presentation of facts, 
making it difficult ro identify specific infractions that would 
automatically lead to a physician's being disciplined- use 
of individual judgment was necessary. Comments included: 
"The board doesn't have any policies or procedures on this. 
We would look at it on a case-by-case basis"; and "We look 
for records, testS, documentation, etc., and lthe board] make[s] 
a decision about discipline. Our practices are very subjec-
tive." One respondent explained: 
We rely on expert testimony. We would consider 
the harm to rhe patient, whether the docror is board-
certified, how long the docror's been in practice, 
whether there's been any prior discipline, or 
whether [there's been] any fraud or financial ex-
ploitation, rhe severity of the problem, how long 
it's been going on, which drugs were used, was a 
patient harmed- ir wouldn't have robe more 
than one patient, though typically ir is - and 
whether or not rhe physician was impaired. [If the 
latter, the physician would go to rehab and the 
board] might nor discipline ... . The goal is pro-
tecting the public and rehab'ing physicians. You 
don't always need discipline to achieve that. 
There was generally les!> c;ubjectivity and inconc;istency in-
' olved in criminal diversion cases ("[The board is] pretty 
consistent; we usually get a drug profile, get records, get 
DEA or police ro investigate that, make a criminal arrest or 
investigate, and get an emergency suspension for 90 days 
.... "). 
For many respondents, violation of a medical standard 
of care was enough ro warrant disciplining a physician for 
opioid overprescribing ("there's no need for a pattern or more 
than one case. One act or omission fai ling to meet the guide-
lines or standard of care is enough if the facts are 
corroborated," and ''the standard really is whether the physi-
cian is practicing below the standard of care and whether 
there's a continued pattern of irregular or substandard care. 
We usually don't have a problem with showing a pattern, 
and if the phyc;ician is below the standard of care, we're 
quick to bring action"). Others commented: "we'd disci-
pline based on failure to meet generally acceptable standards 
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of practice; usually it's based on poor recordkeeping, [rather 
thanl'overprescribing opioids"'; "it's based on adherence to 
medical standards of practice, and proof of that in documen-
tation." 
Respondents mentioned various things they looked for 
when investigating phyc;icians for violating the standard of 
care for overpre!>cribing opioids, including poor maintenance 
of patienr record!Jpoor documentation, "upcoding third party 
billing from a routine to a sick visit when I the visit is Iunder 
five minutes- usually you don't even find a blood pressure 
!charted !-significant findings of another disease entity not 
being followed, like hypertension or hyperlipidemia, not 
monitoring or following up," "red flags in the [patient! record 
like lost meds ... . lllf we see a lot of that stuff, we starr to 
think the doc doesn't know what he's doing. Especial!} 
whether the doctor refers out or not fro a pain specialist], "1s 
"ongoing monitoring, discussion wirh the patient ... in gen-
eral, an absence of appropriate doctunentation to substanti:ue 
their professional decision." One respondent reflected on 
how the pain m:magememsmndard of care hn chnnged: 
What used ro be called overprescribing 5 years 
ago is nor that now. There's been a change in the 
field of pain management. Now we don't disci-
pline for quantiry only. The thinking has changed 
in the practice of medicine. Now we are focusing 
basically on any practice that could be harmful ro 
the patient, and this is based on standard of prac-
tice, which has changed. 
However, a few respondents mentioned that ·tandard of 
care violnrions would typically not be disciplined by their 
board, at lca~t nor without a demonstrated pattern of infrac-
tion by a physician ("we have tO see a pattern"; "it would 
have to rise to negligence on more than one occasion, or 
innppropriate treatment; we'd have a hearing, there'd be due 
process, it would have to be a pattern that was established"; 
and "obviously, any case where we see a pattern of patient 
harm, willful and repeated violation of prescribing laws and 
regulnrions, we'll discipline. Bur we'll probably try to edu-
cate the doc"). One respondenr stated: 
It depends on all the facts, the pharmacy printout, 
and we look at the pnrients - sometimes they 
docror shop. But if it looks like the doctor wa 
fully aware that the patient may have an abuse 
problem and fsl he continued to prescribe, or was 
asked by the board to take a prescribing course in 
the past ... if after that rhe physician is still doing 
the same kind of thing, we'll step up the disciplin-
ary process. 
Bo:ml!. that had adopted pain guidelines referred ro them 
in making judgments about a particular physician's actions. 
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One respondent ·rated: "We look to [our pain rule~ I to give 
us guidance as to whether there's a violation. We rend ro 
[apply] formal disciplinary action with doctor~ who have 
~hown egregious conduct or established a poor pattern of 
practice." Another commented: 
We refer to our pain guidelines. It's not based just 
on dose bur quantity. We realize that people arc in 
pain and need medication for that, bur there come'> 
a point where it's not physically possibl e to con-
sume so many opioicls in such a short period of 
nme. 
One respondent explained rhe benefits of referring to a post-
tion srntement when enforci ng opioid prescribing standards 
for physicians: 
We set up the position statement agaimt legal ad-
vice, because it cloesn 't have the same legal stand-
ing as a law or rule, but it allows us to articulate 
the standard of care in each insrance. Expert testi-
mony is then used when prosecuting a physician 
to show that he did not follow the articulated stan-
dard. For example, the position statement says you 
have ro sec the patient before prescribing drugs 
for them. This rules out Internet prescribing. We've 
gone after four docs for prescribing over the Internet 
without seeing patients first, and we upheld th•lt 
through the position statement. But the position 
statement allow!> us to discriminate [aboutl when 
to go after docs. We don't have to go after every-
body .... The position ~tatement allows a physi-
cian to treat pain, that's standard of care, but it 
doelt say that the physician need~ to com pi}' with 
rhe minimum of appropriate medicnl practice. 
The most common form of anction imposed in over-
prescribing cases was mt111darory education/retraining. Other 
!>anctions included (listed in order of frequency mentioned): 
license suspension, license revocation, probation, restriction 
of opioid prescribing, moni toring of prescribing practices, 
mentoring and supervision, reprimand/censu re, and a fine. 
One respondent srated: 
We classify ou r drug problems tnro three catego-
ries: failure to follow [standards of medical prac-
tice], diverting drugs for self-u!>e, and diverting 
drugs for money, sex, or other thing~. We rake a 
very different tack for all three. For the first, we 
retrain. For the second, we rehab. For the third, 
we have no patience. 
Orher comments included: "frhe sanction! depend!> on the 
severity of the offense, frequency, contrition and recognition 
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on the part of the practitioner, whether he's been before the 
board on an offense"; "1 couldn't say, there's such a range-
everything from revocation to public censure to nothing [to] 
rehab"; "the sanctions differ depending on the case"; and 
I don't always get the sanctions I want. [would 
like tO see temporary suspension of a license and 
mandatory attendance at an appropriate prescrib-
ing workshop. The sanction has to have enough 
meaning to get their attention. Many can write a 
$10,000 check and they don't miss it. ... You've 
got to take them our of the loop a tittle while, get 
their attenrion big time. 
Another respondenr explained: 
If it's limited to a lack of knowledge, we have a 
lot of cools to evaluate what to do .. .. [I]f it's a 
pretty big problem, we end them to get a report 
o n their skills/knowledge .. .. [I]f it's a minor 
knowledge base [probJem], we send them to a 
remediation program .... If there are other quality 
of care issues, we send them to an evaluation pro-
gram. Then with doctors trading drugs for sex, 
that's a character problem; we wouJd invoke long-
term [license) suspension or revocation. 
Opioid underprescribing: Complaints 
Nineteen respondents (50 percent) were aware of complaints 
to rheir board against physicians for undertrearrnenr or inad-
equate treannent of pain in 2001. Based on the thirty-three 
respondents who were able to estimate the number of com-
plaints, the average per 1,000 doctors in the State was 0.46 
(standard deviation = 1.1, range = 0 to 5 .9). 19 The major 
ource of such complaints was patients (eight respondents 
identified nonprisoners as the major source, two identified 
p riso ners, and five reported both prisoners and 
nonprisoners).40 The other primary source of complaints was 
family members (nine our of nineteen). One respondent ex-
plained: "!There arc] three major sections that prescribing 
complaints can fall under: unprofessional conduct, incom-
petence, and fraud. Dnadequate pain management complaints 
are] usually in the first two categories." Some felt this prob-
lem was underreported ("it's a very underreporred problem, 
in my opinion"; and "I've had orrhopods proudJy say they've 
never written for a Schedule 11, and my quesrion is 'Why? 
Aren't you dealing with people with severe pain ... ?' So I' m 
sure there's undemeatment, we just don't see the formal 
complaints."). A few respondents did not perceive 
undercreatmem of pain ro warrant a serious response by the 
board ("fwe've received] just a few [complaints about 
undertreatmenrof pain]. Normally those were dismissed or 
no action was taken because the board doesn't perceive that 
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circumstance as a real high threshold of some kind of negli-
gence o r incompetence."). Othe rs demonstrated a 
commitment to the issue, despite the absence of complaintS 
("as a cancer survivor I' m sensitive to rhe issue, but I don ' t 
see complaints from cancer patients saying rhe doctor didn ' r 
treat my pain carefully" and " I've kind of looked for them, 
but haven't found any so far. "). 
A few respondentS gave examples of inadequate pain 
management complaints as being revealed, through investi-
gation, to be instances in which patients were actually 
receiving adequate doses of opioids or were addicted to opio-
ids and then complaining that they were cut off from their 
source of drugs. One respondent explained: 
We did have one doctor who was overprescribing 
her patients who were addicted to narcotics, and 
after we suspended her license, some of them 
called to complain they couldn't get their med , 
bur those were [addicts trying to get narcotics, so 
it's not a legitimate complaint of undertreatment 
for pain]. 
Twenty-seven respondents (71 percent) thought there had 
been no change in the number of complaints the board had 
received in the past 5 years regarding inadequate treatment 
o f pain. Six respondents thought there had been more com-
plaints, and rwo thought less. Three had no opinion. Those 
who thought the number of complaints had increased attrib-
uted it to increased public awareness ("on a personal level I 
find [awareness about this issue to have increased) in hospi-
raJs; my husband recendy bad surgery and they were constandy 
asking him about pain- having him score his pain every 
time you turned around''). 
Investigations and discipline for underprescribing 
Respondents were asked to estimate the number of investi-
gations their board had ever conducted related to pain 
undertreatmenr. N ineteen respondentS thought their board 
had never investigated a physician for undertreating a patient's 
pain, and sixteen thought their board had. (Three did nor 
know.) Of the latter sixteen, eleven were able to e~<imate the 
number of investigations their board had ever conducted re-
lated to underrrearrnenr of pain. The average number of 
investigations was 1. 7 (standard deviation = 3 .4, range = 0 
to 13). Six respondents said all the cases involved 
nonprisoners, three said they involved only prisoners, and 
three said borh prisoners and nonprisoners. Four did not 
know. One respondent pointed our that physicians are not 
required to "treat every patient who comes in rhc door," so a 
physician may refuse to refill a new patient's request for 
opioids- this is different from a physician failing to treat 
people under his or her care. Only one board had acwally 
disciplined a physician for undertreatment of pain. 
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Respondents were given facts from the case regarding 
Dr. Bilder, the physician who was disciplined by the Oregon 
Medical Board for undcrtre:lting his p:~tien ts' pain. Seven-
teen re!.pondent!> were familiar with the case, ten were nor, 
and eleven were unsure. When asked how likel y the 
respondent's board would be to rake disciplinary action again t 
a physician for whom the board bad received similar com-
pbints that were later corroborated, eleven re pondents 
thought it was almost a certainty (i.e., greater than 90 per-
cent), fourteen respondents thought it was probable (60-90 
percent), three thought it possible (40-60 percent), two 
thought it unlikel y ( 10-40 percent), and three gave other 
ranges (between 60- 1 00 percent, and between 40-90 per-
cent). Five could nor say. 
Respondents' comments added further insight. Some 
stared that their board is limited in the kind of disciplinary 
action it can take ("the law only allows us to take disciplin-
ary action if they're grossly negligent"; "we have to use clear 
and convinci ng evidence ro prosecute, and that's a pretty 
high ~tandard of evidence''). Several respondents commented 
that each case is unique and ir would be difficult to predict 
their board's response ("it depends on the facts" and "the 
board tries nor ro make pronouncements on types of cases 
because they're dependent on facts and circumstances. The 
doctor may be making the right judgment in that particular 
situation, it may be appropriate. There are no cookie-cutter 
answers for these cases."). Some noted that more than one 
instance of pain undertreatmem would be necessary ("you 
can't establish a pattern of practice with one patient"). Oth-
ers looked for level of egregiousness ("The decision would 
be based on rhe medical record, and if there was a danger to 
the health, welfare, and safety of the community, that would 
definitel y be a legal basis for [disciplinary action]. If it was 
found that the situation was egregious, there would be a 
legal basis for a summary suspension.''). 
A number of boards appeared disinclined ro consider a 
standard of care violation alone as a basis of disciplinary 
action in cases of pain undertrearmenr (''the board tends nor 
ro discipl ine based on !.tandard of care but on [gross] negli-
gence"). One respondent voiced frustration witb this general 
tendency of rhe respondent's board: 
My problem here is we see standard of care [vio-
lation! cases all the time, but we don' t discipline 
on [violation otl standard of care. For some reason 
our reviewer .. . says, "well, it's not the best medi-
cal care, bur ir doesn't rise to the level of gross 
negl1gence." I wonder, what consrirutes gross 
negligence? ... I don't think we do a good job at 
all on standard of care. I'd like to think so, but we 
don't. 
Some respondents thought that the physician's intent would 
be relevant ("was he trying to avoid DEA scrutiny rather than 
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intentionally make people suffer?"), implying that a physician'<> 
lack of knowledge about adequate pain management would 
be grounds ro evade board sanctions for pain underrrearmenr 
("You would almost have to show criminal cruelty. [Giving 
Tylenol for cancer pain, knowing it doesn't alleviate the pain,] 
could show that."). However, a few thought their boards 
would discipline if they could prove that rhe ~randard of care 
had been violated ("yeio, standard of care would be disci-
plined, depending on rhe facts"; "we do discipline standard 
of care issues; it's hard to prove someri mes, but we do •·; and 
'·if the physictan is just disregarding the paricnr's complaint 
[and the patient's] nor getting better, ::.tandard of care dictates 
that a follow-up is required and, if [that does! not [happen], 
then standard of care is not met"). 
Tho"e whose state medical boards had pai n manage-
ment guideline!. or end-of-life legi!>lation used those guidelines, 
policies, or legislation ro benchmark the phy!>ician's actions. 
One respondent stated: "that\ just cruel ro those patients, 
and ir\ nor in conjunction with r our] pain management guide-
lines." Anmher explained: "our state has pain rules that were 
made by the board that the physician is expected to follow, 
and if it was verified that rhe physician didn't fo llow them, 
as would be the case with the physician in this scenario, that 
physician would most likely be disciplined." Another com-
mented: 
A doctor would have ro ~how a pattern of practice 
of undertrearment, and following our pain guide-
lines, if the patient's pain was 10 our of 10 and 
[he's] giving Tylenol or ibuprofen, that's really ri-
diculous. Our consultants are in pain management 
and they believe in treating for pain. [Bur] it's hard 
to gauge '> ince we've never [disciplined fo r 
underrrearment of pain] before. There arc eigh-
teen different personalities on our board, and it's 
hard to say how they'd go. 
Yet another respondent stared: 
In [this sratel you're not held criminally liable for 
judicious ritration in cancer patients, so ro get an 
undertreatmenr case, you just have to have a rea l 
lack of education, and if we saw that, we'd have 
to utilize some discretion. Why ditl it happen? 
Can the physician be educated without sanction 
and snll protect the public? 
Several re~pondenrs thought that, depending on the facts 
of the case, a physician would likely be educated about pain 
management before sterner o;anctions were invoked. One 
respontlent!>tated: "they wouldn'tsuspend a docror's license 
probably, they would probably want re-education. Some of 
those programs here are very expell!.ive, but rhe board doesn't 
let that srop them from recommending such a course." An-
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orher explained: "if it was an innocent mistake ... and if 
there was no pattern .. . the remedial board would review 
another 1 0-20 charts of that doctor, in a very collegial way, 
and tell him what he needs to do, and [make it clear that] 
'we don't wanr to sec you again."' One respondent won-
dered whether sanctioning a physician for underrreating pain 
would lead to overprescribing problems ("once you disci-
pline someone . . . they can go the other way. I've had 
physicians say, 'Fine, I get disciplined for nor doing it, I' ll 
give everybody drugs. '"). One respondent thought," If you're 
just coming in and spanking people, [that's not helpful] ... 
doctOrs [needl good messages, roo .... Our goal isn't just to 
discipline as much as we can." However, other respondents 
thought their board was roo lenienr in dealing with physi-
cians for undemearing pain. 
Use of pain management experts 
Respondents were asked whether their board ever used a 
pain management expert ro assist with an investigarion in-
volving the prescribing of opioids (either underprescribing 
or overprescribing). Thirty-one respondents said their board 
had used such an expert. The mean percencage estimate of 
cases 111 which a pai n management experrwas used wa!. 29.2 
percent (standard deviation ::::: 35 .0, range from 0 to 100 
pcrccnc).~ 1 This result must be interpreted cautiously, as some 
respondents qualified their answer by staring thar the de-
nominator of rbeir estimate was investigations involving 
opioid prescribing for pain management, nor opioid prescrib-
ing for criminal cases (e.g., physicians illegally prescribing 
opioids in exchange for ex or money, or self-prescribing). 
One respondenrexplained: "we have pain managemenrguide-
lines that we've published, and it's easy ro compare :.t 
physician's behavior ro those guidelines, but I'd say we refer 
to a pain management expert in about 20 percent of the 
investigations, bur they [also] use our guidelines." Another 
stated: "in a case right now we're using a pain management 
expert, bm that's only the second or third time. Usually the 
ca~es are pretty clear." Some respondents stated that their 
boards use a pain management expert whenever disciplining 
a physician for opioid prescribing practices, or whenever the 
board has a hearing in which someone te~tifies agaim.t rhe 
physician for issues related to opioid pre:-.cribing. One re-
spondent explained: "if the nexus of the case is pain 
management, then a pain management experr is involved." 
One respondent noted rhat recent legislation required that a 
palliative care physician sir on the board. Another stared: 
"with our budget problems, [we don't use a pain manage-
ment expert! as often as we'd like ([only] about 20-25 percent 
[of the rime]). [There's] a pretty good mix o f physician~ on 
the board and subcommittee. They usually do okay, but some-
times rhey need the expert." 
When asked to name the credentials of the pain man-
agement expert used, five respondents menrioned board 
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certification in anesthesiology, twelve mentioned certifica-
tion in pain management (mosdy through anesthesiology pain 
management certification), seven mentioned experience-based 
expertise (''usual ly it's a doctor who's well-respected in the 
community and works for a pain clinic or runs a pain clinic"), 
and one mentioned a combination of experience-based and 
pain-management-credentialed experrisc. Six did nor know. 
Sever:.tl mentioned that they try to march the specialty area of 
the physician being investigated with rhat of the consultant 
("If it's a family physician, we look for a family physician 
who also trear.s chronic pain patients."). One explained: "very 
few physicians are board-certified in pain managemem, [bur] 
there are a lot who practice pain man:.tgemenr. We would get 
an internist if an internist was involved, ere." Another reiter-
ated: "few people are certified in pain management, though 
most [experts] we use, that'<; their main specialty. They ad-
vertise rhemseh·es as pain managemenr experts. Most are 
board-certified in their primary specialty at leasr. A handful 
arc board-certified in pain management, but not a lor." 
Potential chilling effect 
Several respondents commented about the potential chilling 
effect that could be created by the board's investigations of 
and disciplinary actions against physicians for opioid pre-
scribing. Some wondered how these fears were propagated. 
One commented: "the thing that surprises me is that physi-
cians won't prescribe because they say they will get in trouble 
from rhe state. Where do they get this idea? ... It's always 
baffled me where they get that from. Urban myth." Another 
srated: "there's a perception by many GPs or internists that 
we are something much bigger than we rea lly are. It's the Big 
Brother syndrome, like the IRS, a bigger perception rhan 
man} of us in the regulatory business are really aware of." 
Others thought there might be some truth to such concerns, 
as is conveyed in the following comment: 
It has gotten out that the board is very active and 
this has created the feeling of some in the medical 
community that we're out to get them. And some 
have asked me ifl'm worried that we're being roo 
aggressive, and I do worry about thar. Bur 1 worry 
roo that they'll forger we're here. 
Anorher responded similarly, emphasizing that the interest 
in avoiding a chilling effect must be balanced with the board's 
obligation to protect patients from harm: 
Doctors like to cry foul anytime we inquire about 
anything, and say we've scared them so they're 
no t going to prescnbc anything. lr's just a problem 
we h:.tve to deal with on a case-by-case basis. There 
are doctors out there who arc harming their pa-
tients, and we have ro protect rhe patients too. 
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Board-sponsored education/trainillg 
Twenty-eight respondents stated that their bo::~rd had distrib-
uted educational materials regarding treatment of patients 
with pain. In most cases, these were arricles in newsletters 
or publication of the board' pain man::~gemcnr guidelines or 
rules. Others mentioned distributing press releases, white 
papers, and pamphlet on the ~ubject. M::~ny of the bo::~rd s 
provided the same information on their website. One re-
:-pondenr sratcd rhar "our position statement on pain 
managemem is given ro physicians when they're licensed, 
and they're interviewed by a board member to reinforce their 
knowledge of [the position statement]." Others covered ap-
propriate prescribing for pain in mandatory orientation 
sessions for new physician licensees. In one stare, "any new 
physician who applies has to take a written test based on all 
rhe board's rules, [including appropriate opioid prescribing]." 
Several respondents emphasized that the focus of these edu-
carional efforts was on proper documentation and follow-up 
of patients treated for pain, particularl y for chronic pain, 
e.g., ''The [emphasis .I thar our board has [stressed wirh.J phy-
sicians is documenting their treatment plan, diagnosis, and 
rationale for what [they're] prescribing. That's where physi-
cians will get into trouble. It's necessary for the patient and 
good for the doctor; for example, if the patient needs ro 
change physician , those records speak volumes"; and "We 
sent ro phy'iicians [in rhe state! ... a letter saying basicall y 
'we don 'rwant you to overtreat or undcrrreat [your] patients' 
pain, and if you ever have a complaint with us, this is what 
you need ro hnvc in yourfile, and if you don't have it, you'll 
probably be in trouble with us." One respondent questioned 
whether physicians were "getting the message": 
!Thi:. state I has specific legislation in this practice 
!chronic pain management I and how it's supposed 
to be done. We have shared tharwirh physicians in 
our newsletter, and we give talks, but rhe word 
doc&n't seem to get our. Physicians who we find 
are overprescribing complain that "the board's 
picking on me," bur we're nor. It's an issue of 
good medica l practice. 
Another expressed frustrati on with the limitations of whar 
could be accompUshed by a nonauronomous board: 
My board .... can'tdo a lor of things because [we' re] 
under an umbrella agency that administers our 
budget and other things. We can complain but are 
limited in what we can do .... such as writing/ 
distributing educatioml brochures and all kind s 
of creative things .... I work wirh "inside the box" 
type people, which you see in government agen-
cic.:s a lot. Creativity and innovation arc nor en-
couraged, and when you achieve them, you've had 
tO fighr hard. Everything is a struggle. 
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Fourteen respondents reported that rheir board had pro-
vided educational sessions on the treatmen t of patients 
with pain. Some were talks and presentation!. about pain 
management given at hospital<> or other venues. Onere-
spondent reported: "I We've l sent sraff out ro give presentations 
and have been keeping track of those since 1999. I have a 
li:.t five page long of all the places we've gone: 137 pre-
senratiom since 1998, 38 jwercl pa in manageme nt 
speeches, and 25 !were I overviews with pain management 
references as parr of the content." Another sr~1ted : "the ex-
ecutive director has spoken on this .... We try to be as 
proactive as we can." Others mentioned full- or half-day 
seminars or training sessions provided by the board on 
pain management and proper prescribing- some were 
one-rime sessions and others were given annually or more 
often. One respondent referred to a recently passed bw re-
quiring physicians in the state to take" 12 hours of CME 
[conti nuing medical education Jon end-of-life care and pain 
management" as a possible solution to rhe problem that "a 
lor of people our there are nor bei11g treated appropriately for 
their pain, and doctors don't recognize thar. ., Another board 
was "also looking at mandatory CME in pain management 
for physicians." 
Of the twenty-four respondents whose boards did nor 
provide educational sessions on pain management, comments 
included: "this is being discussed, [bur it's I available in the 
private sector"; "we're talking about providing CME on pain 
management and end-of- life hospice issues, bur ... nothing 
has been finalized" ; "we defer to Purdue and other work-
shops"; and '' I wish we had rhc sraff; however, there are 
rea l.ly terrific people purring CME sem inars on in the com-
munity that are excellent. There's a wealth of resources in 
rhis area, so there's no excuse for nor having knowledge 
about pain management." 
Balancing the need for appropriate treatment with 
preventing abuse and diversion 
A few respondents thought rhat physicians might be hesi-
tant to prescribe opioids to terminally ill patients ou r of 
fenr that they might hasten rhe patient's death. One re-
spondent said rhar the allegations made to rhe board rel.ning 
ro underrreatmenr of pain typically involved "a fundamen-
tal value system" in which physician), "have very strong 
feel ings about nor wanting to hasten a patient's death." T n 
such cases, the board "trie!sl to assure phy<;icia ns that it 's 
within accepted practice to palliate at the end of li fe and 
this is not seen as eu thanasia or physician-assisted sui-
cide, but often physicians really struggle with rhar issue." 
Most respondents, however, fel t that pain management ar 
the end of life had seen the most improvc.:menr as fa r as 
boards being better able to distinguish adeqnare opioid 
prescribing from ove rprescribing, as is evident in rhe fol-
lowing comment: 
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The board's in a rough spot. As soon as it goes 
after someone for overprescribing, the first reac-
tion is "that's chilling treatment for pain." They 
duck for cover under that. Bur those cases are 
apples and oranges. Those who are diverting apia-
ids take cash only, they deal with patientS who 
have a criminal history, they don't keep records. 
There's no comparison to, for example, treating a 
dying cancer patient. Complete apples and oranges. 
It's not like someone in hospice, dealing with a 
patient who needs pain medications. Our board 
has a posi tion statement on end of l.ife that covers 
all this. 
Some respondents commented on the difficulty in rec-
onciLing the changing atrin1des and practice standards in pain 
management of reccnr years with the ongoing problem of 
drug abuse and diversion. One stated: "it's a real challenge, 
finding that balance betw·ecn under- and overtreating pain." 
One pointed to the difficulty of managing pain in the fragile 
elderly: "what might be an appropriate dose for a young per-
son is not for an elderly frail person who's on multiple 
medications." For some respondents, their job was easier 
when there was a clearly established upper limit for pre-
scribing opioids, as the following comments demonstrate: 
[There's been a] tremendous change in the man-
agement of chronjc pain and the attitude that there 
doesn't seem to be any upper limit on opioids. 
The attitude now is "whatever works." 1 have prob-
lems with that because ['m faced with figuring out 
whether opioids are being diverted or not, and I 
have suspicions that a lor of patients are conning a 
lot of doctors into giving them meds and don't get 
questioned because of this "whatever works" atti-
tude. We will have to figure out how to counter 
that .... We used to sanction based on the PDR 
[Physicians' Desk Reference] limit (like 40 mg a 
day for oxycodone), but now that's almost never 
the basis of OLlr sanctions. Patients are on 700 to 
800 mg of oxycodone a day. 
The numbers we're seeing, the doses are kind of 
unreal at rimes. You have a physician who's not 
educated in pain management, and this mjght sound 
bad, but there is this rhetoric aboutservingchronic 
pain patients, so physicians tend ro do it. Some 
have good hearts and don't know how to do it 
well; some don't have the heart but see it as a way 
to have a practice. But they're not following good 
medical practice in prescribing, they're just pre-
scribing. They don't have consults, they don't docu-
ment about what's going on-sometimes it's not 
even based on good pharmacology, just "oh, this is 
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good." Underprescribing is still an issue, but there's 
also the issue of people being so overprescribed 
-we bad one woman who was a school bus driver 
and she couldn't even move [because she was so 
drowsy from the prun medication]. 
The following respondent's comment concerns the same is-
sue - how to balance treating valid chronic pain with 
protection against abuse of opioids: 
Chronic pain in my opinion is a subspecialty. Even 
expertS don't agree [on] what to do. The problem 
1 have is not so much with the pain specialises, but 
at rhe ... level of general practitioners and inter-
nists who end up with patients with chronic pain. 
Sometimes they do a good job at handling it, some-
times theydon'r. A lot of these doctors don't know 
how to say no to patients, they don't really under-
stand whar's going on. They can get into trouble if 
they take everything a patient says at face value. 
How do you know if I really have a migraine? ... 
It'-; hard. No doctor really wants to bother with 
the chronic pain issues. I knew a pain manage-
ment specialist who said it took 3 months for her 
to get a feel for whether certain chronic pain pa-
tients were lying to get meds. Everyone lies. We've 
had physicians lie who are under investigation, 
and if physicians lie, you can bet patients lie. 
One respondenr agreed that many physicians prefer not to 
treat patientS with chronic pain, and that it is better for them 
to refer such patientS to a pain specialist: 
Some chronic pain patients are tough to treat and 
some doctors feel they don't have the time rospend 
with those patients. One of the things I always say 
is don't dabble in pain medicine. Do it right, for 
the sake of the patient and the doctor. It's better to 
refer [patienrs to a pain specialist] than to do it 
haJf way. 
Yer, another respondent identified the problem of the lack of 
access to qualjry chronic pain treatment in pain clinics and 
centers: 
One of the problems is that the pain clinics arc 
undersupporred, they're short of doctors willing 
to practice pain medicine/anesthesiology, they can't 
get paid. [This causes a] population of people to 
seek out individual physicians, some of whom lack 
the skill set to treat this type of patient. It's a diffi-
cult problem. One psychiatrist opened a pain 
clinic, no prescribing experience before. He's gone 
from none to the top three OxyContin prescribers 
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in the state. So, how does thar happen? With vir-
rually no records kept. People are walking in with 
money. 
Another agreed: 
It's the standard of care tu take care of people's 
pain just like it's the standard of care not to be 
duped. That shows how colossally difficult the 
board's job is here. When do you cross over from 
appropriately treating pain to hurting patient!)? [ 
think people get into trouble with tlli.s because it's 
easy money for doctors. l think the brass ring is a 
pain center connected with an academic center, 
where they're well-trained, well-managed, look 
at all problems, not just pain. Patients who are 
marginal and might be abusers are put on con-
tracts and rhey have ways to keep them from par-
ticipating in diversional activity ... . I'm always 
impressed with these pain centers ... they make it 
undesirable for drug-seeking individuals to [use 
their services.] 
Several respondents commented further about the diffi -
culty boards have distinguishing valid chronic pain from 
drug-seeking behavior. One srated: "With the advent of new 
end-of-life legislation ... physicians ... feel freer to go ahead 
and prescribe the pain medications that are needed. This 
helps a lot. Regarding chronic pain, physicians arc much 
more cautiou~ about that." Another acknowledged: 
I r's easy if the pntiem is terminal. It's not so easy 
with intractable pain. Is rhis a drug-seeking pa-
riem or a patient with valid intractable pain? That's 
a difficult call for physicians and a difficult call 
for us. Maybe with rime there will be more so-
phisticated diagnostic tools available w make it 
easlCr. 
DISCUSSION 
Our study results indicate significant variation among state 
medical boards regarding experience with and reaction to 
overprescribing and underprescribing opioids for pain treat-
ment. With respect to overprescribing, states were divided 
on their perceptions of whether the number of complaints, 
investigations, and disciplinary actions for opioid overpre-
scribing over the past 5 years had increased, decreased, or 
stayed the same. The largest group, in each case, indicated 
they thought the numbers had stayed the same. A slightly 
smnller, bur significanr, group thought they had increased, 
and only a few believed they had decreased. However, it 
appears from the data that there was consistency in responses 
regarding trends in complaints, investigations, and di5cipl.in-
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ary actions. That is, if the number of opioid overprescribing 
complaints was perceived to have increased in a jurisdiction, 
the number of investigations and discip linary actions ei-
ther increased or stayed the same. Likewise, if the number 
of compbints stayed rhe same or decreased, rhe number 
of investigations and discipli nary actions either stayed the 
same or decreased. These results were based on perceptions 
(rather than actual numbers), as it is still the case that most 
rate~ lack systems that track complaints based on opioid 
prescribing. 
We questioned whether rhe presence of a state prescrip-
tion monitoring program might have had nn influence on the 
number of complaints or investigations related ro opioid pre-
scribing. Compared to respondents from states without an 
electronic prescription monitoring program, we found that 
respondents from states with such a program were genernlly 
more likely to think the numbers of complaints, investiga-
tions, and disciplinary actions against physicians related to 
opioid prescribing had stayed the same over the pasr 5 years 
rather than increased or decreased (see Table 2). Regarding 
estimates of thl! number of opioid overprescribing and 
underprescribing complaints received in 2001, there were 
no statistically significant differences betw·een boards with 
and bonrds without an electron ic prescription monitOring 
program. Thus, based on respondents' estimates and percep-
tions, it docs not appear that electronic data tracking 
mechanisms led to increased numbers of complaints, inves-
tigations, or disciplinary actions against physicians reb ted ro 
opioid overprescribing practices. 
While nearly rwo-rhirds of respondents reporred rhat 
opioid overprescribing complaints had decreased or srayed 
the same, over a third of respondents perceived thnr opioid 
overprescribing complaints had increased in their jurisdic-
tion during the past 5 years. This appeared tied to a perception 
that drug diversion, in general, had been increasing. A sig-
nificant number of respondents believed that drug diversion 
on the whole was worse in their state than it was 5 years ago, 
although some attributed this ro more diligent efforts w seek 
our such diversion. Of the eighteen respondents who thought 
drug diversion had worsened in their state, fifteen thought 
that OxyConrin had significantly contributed ro this prob-
lem. On rl1e other hand, of the thirty-three respondents who 
had an opinion on this issue, fourteen (42 percent) did nor 
think OxyContin was a problem in their state. This is likely 
due to the variation in abuse patterns of OxyContin across 
the nation. A large majority of respondents stared that their 
board had not changed its investigative approach in light of 
OxyConrin concerns, but the overall tone of their comments 
regn.rcljng drug diver ion indicated rhnt, in general, their boards 
had taken more active steps to address this problem. 
As regards decisions ro investigate physicians for over-
prescribing, it appears thara number of boards are arrempring 
ro find the appropriate balance between identifying physi-
cians who overprescribe and rhose who are appropriately 
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treating patients with chronic pain. A number referred to the 
fact that their board had developed a policy or guidelines for 
prescribing for chronic pain that were a significant aid to 
rhem in deciding whether ro investigate or discipline a physi-
cian. The number of boards that have adopted pain management 
guidelines, regulations, or policies has, in fact, increased over 
the last 4 years, with boards specifically addressing the issue of 
chronic nonmalignant (o r "intractable") pain. In 2001, the 
PPSG documented a total of eighty-two state pain policies in 
the form of stawtes, regulations, guidelines, o r policy state-
ments. As of 2001, twelve states had adopted the FSMB's 
Model Guideli nes in full, and nine in partY 
It is unclear to what degree the existence of such poli-
cies correlates with a board 's commitment to educati11g 
physicians about pain management and opioid prescribing 
issues (i .e., to mitigate the chi ll ing effect that has caused 
physicians to avoid prescribing opioids when they are needed 
to treat pain). Although the findings reported here must be 
i.nterpreted cautiously, it appears that boards with state pain 
policies that address the treatment of chronic, nonmalignant 
pain are more proactive, in that these boards provide more 
pain-management-related education to physicians than boards 
that do nor have such policies (see Table 3). However, we do 
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not know whether the content of such educational efforts 
strives to balance education about overprescribing with that 
of pain w1dertreatment concerns. More research is needed 
to determine what speci.fic messages boards are sending to 
physicians in these educational efforts, how physicians are 
interpreting these messages, and how such educational ef-
forts are affecting physicians' opioid prescribing practices. 
Respondenrs' commenrs indicate that boards are focus-
ing on making their pain policies known to physicians so 
that physicians are aware of what is required of them to 
avoid scrutiny by the board. A number of boards empha-
sized what should be present in the patient's chart to avoid 
suspicion by the board that the physician is overprescribing 
(e.g., patient assessment, pain diagnosis, plan of care, evalu-
ation, follow-up, specialist referral) . These efforts serve to 
reassure physicians that they will not be disciplined for over-
prescribing opioids ro patients with chronic pain if they 
conform to standards of practice and state pain policies. On 
the other hand, if a physician is accused of overprescribing 
and lacks proper documentation of his or her practices, he 
or she is much more likely to be investigated and disciplined. 
Al1 encouraging result for pain managemenr advocates 
is that boards appear to be moving away from volume or 
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quantity of opioids as a primary basis for investigating a phy-
sician for overprescribing opioids. Some respondents referred 
ro volume as a trigger but not conclusive evidence for a deci-
~ ion to investigate. Many respondents indicated that these 
were very fact-specific cases that had to be evaluated indi-
vidually; that all facts, including the diagnosis of the patient, 
the documentation of the prescriptions ordered, and consis-
tency with established guidelines, had to be considered. 
Despite this positive trend away from using volume a a de-
terminative factor in moving f01·ward to investigate or 
discipline, a few respondent comments were troublesome in 
that they implied a continued reliance on volume and, in at 
least one case, a lack of knowledge regarding issue of dos-
age and volume. For example, the comment, "It's nor based 
just on dose bur quantity .... there comes a point where it' 
nor physically possible ro consume so many opioids in such 
a short period of time," might be accu rate if referring to an 
opioid-na'lve patient. However, it is possible that a patient 
with intractable pain might be adm inistered large doses of 
opioids wirh a sharp dose escalation (i.e., large doses in a 
shorr period of time) in order to obtain pain rel iefY Thus, 
misunderstandings sti ll . eem to exist about opioid volume 
and quantity upper li mit<> (i.e., that the latter exists indepen-
dently of case-specific facts, which is generally not the case). 
In response to the question regarding factors that the 
board would consider in deciding whether ro discipline for 
overprescribing op.ioids, most respondents stated that it was 
a matter of judgment, that it was very fact specific, and often 
subjective. However, for those that had established pain 
management policies or guidelines, these appeared key in 
determining whether to discipline. Significant departures 
from the policies, in some cases, could be a basis for disci-
pline. Boards varied regarding whether they would require a 
pattern or more than one instance of overprescribing before 
disciplining. Poor documentation and recordkeeping were 
also consistentl y cited as key factors in disciplining physi-
cian in the e cases. A number of boards also mentioned 
using pain experts to assist them in deciding whether to dis-
cipline in cases of overprescribing. A lack of availabiury of 
credentialed pain experts may interfere with some boards 
getting the professional guidance they need to investigate 
physicians for opioid prescribing practices. 
Over half of the respondents (55 percent) th ought the 
number of board disciplinary actions relating to opioid pre-
scribing practices had either stayed the same or decreased 
over the past 5 years. Respondents who observed a decrease 
offered reasons that were encouraging for advocates of better 
pain management. These board repre enratives thought their 
board's attitude toward opioid prescribing had changed over 
rhe past 5 years and that their pain management gu idel ines 
helped them in a number of cases determine that the pre-
scribing practices of rhe doctor under investigation were 
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wcb1i11t. See Puil1 & Policy Studie.1 Group. UniversiTy of Wisconsin Comprehensire Cancer Cem er, Data-base of State Laws, Regulations. and Other 
Oflici~l Government Policies. at <http:/lwll·w.med.rch.wi\·t·.edu/painpolicylmatrix.lmn> (last updmed November 5. 2002). 
'~'Rc.,pmuit•l!t\ were ct.1kt'd: Hll.l wmr hoard distrilmtnl tillY edtll·mioHal material~ regarding Treatment of pmiellls 11·ith pain (e.g .. copy of guidelines. 
nett ~leuer.1, brod111re.\, t•itletH)? Ha., your board held tilly educationol sessiom 1m treatment vf patients wiTh pain? Does the board tJrot•ide any 
additional CIISiltWiet' to 1•hy.licitl11S .reekiHg guidcmce .for tile tr.:mme/11 tifpatients with paiu? If responde/lis a11swered affirmatively. they were a.1ked 
10 de~ui/1e thl' Tl'/11'.\ of nwteria/.1. seS.I'ion .~. or additional anistance. lnformatiOII here is based 011 a content wwlysis of respol!dents " commenTs. 
Perct•mnge.l art• t•alitl tow/~. Mi.1si11g dow art• tile result of n•sponde11ts 11'1111 1"0111pleted (t ll"rillc'll ,111rvey. cmsll'ered ··yes·· to ony of the questimu. hm 
did 11(1/ provide qualttwn•e elabomtion. 
**Tin·.1e an• .\Ill/lite.\, n•gulatio11.1, guit!t>liue.l. or policies then oddreH treatmem of or opioid prescril>illf! for duouic. 11onmalig11al11 poi11. 
•**Thew- includi•d paiii-IIICIIIIIJil'lllf!lll·rt'imetl /Jroc/1/lre.\·. topie.s t({ pain pl)/icies, position statements. and the like thm were al'flilable upon request 
wul/or diHrilmted to physicians (e.g., b)' mnil or other metlwds n.f distribution). 
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reasonable, where prior to the adoption of the guidelines 
they might have disciplined the physician. 
The number of estimated complaints boards received 
for undetprescribing were significantly fewer than those re-
ceived for overprescribing (in 2001, an average of 0.46 versus 
3.13 complaints, respectively, per 1,000 doctors in the state). 
A significant majority saw no change in the number of com-
plaints received for underprescribing over the past 5 years. 
While some respondents thought the problem of pain 
underrreatmenr was real and merely underreported, others 
did not seem to view undertrearing pain (particularly chronic, 
nonmalignant pain) as a significant problem. 
While nor equivalent to complaints received for over-
prescribing, it appears cl1ar the number of complaints for 
underprescribing has increased. Martino conducted inter-
views with medical board executives between November 
1997 and January 1998.44 At that time, only one board (Cali-
fornia) of the thirry-six surveyed had received a complaint or 
report explicitly alleging undertreatment of chronic pain. 
Several had received complaints from prison inmates alleg-
ing that certain medications had been denied as a form of 
punishment, but they generally were not pursued as pain 
underrreatmenr cases. 
As regards disciplinary action for undertreating, many 
boards appear disinclined to discipline simply for v.iolation 
of standard of care, which is how many respondents de-
picted cases of underprescribing pain medication. They would 
be more Likely to recommend education to the physicians in 
such cases. This appeared somewhat at odds with the re-
sponses given to questions about disciplining for 
overprescribing, where respondents said they were more likely 
to discipline for violation of standard of care, even without a 
pattern of poor practice. Thus, there is a lack of parity in 
application of standard of care and patient harm as bases for 
discipline in cases of undertreatment versus overrreatment. 
Overprescribing is more often seen as a clear violation of 
standard o£ care and a clear example of patient harm, while 
many respondents, or their boards, do nor view 
underrreatment, particularly for chronic pain, in the same 
way. They appear to apply a higher threshold of harm for 
undertreating pain. 
A nurnber of respondents, however, did provide examples 
of cases they thought could be construed as gross negligence 
or egregious behavior regarding pain undertreaanenr and said 
that such ca es might lead to disciplinary action. Consistent 
with this response, a significant majority of respondents (79 
percent) said that if they were presented wicl1 a case where 
the facts were similar to those of Dr. Bilder (the physician 
who was disciplined for underprescribing by the Oregon 
Medical Board), it was either highly likely or probable that 
they would discipline rhe physician. 
In regard to the potential chilling effect of the board's 
efforts to oversee opioid prescribing practices, some respon-
dents showed concern mat physicians might "go the other 
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way" (i.e., overprescribe opioids if disciplined for undertreating 
pain, and vice versa). Some boards were working diligently 
to ease physicians' fears that they would be investigated or 
disciplined by the board for prescribing opioids to patients. 
Several thought such fears were completely unfounded or 
perhaps a convenient excuse to avoid the added work in-
volved in treating chronic pain patients. Others realized that 
the board's actions had a chilling potential, but thought there 
was little tl1ey could do, that it was the physician's faul t for 
jumping to false conclusions, and that such is the price that 
is paid for protecting patients. These respondents were aware 
of the problem of inadequate pain management, but seemed 
to give more weight to concerns about overprescribing. 
Respondents spoke of"prorecting patients from harm," yet 
did nor view opioid overprescribing and pain undertreatmem 
equally in the degree of public protection rney demanded. 
This type of attitude may contribute to a shortage of physi-
cians who are able and willing to treat patients who have 
chronic pain. While advocacy for pain management on the 
part of many state boards may ease physicians' fears about 
being disciplined for opioid overprescribing, many physi-
cians may decide that their safest (or least burdensome) 
course is to refer patients with chronic pain to a pain spe-
cialist. With the number of patients suffering from chronic 
pain greatly outnumbering the number of qualified pain spe-
cialists, the results do not add up in favor of those with 
chronic pain. 
CoNCLUSION 
In sum, we cautiously conclude from out survey results that 
the attimdes and practices of medical boards toward physi-
cians' prescribing of opioids have changed for the berrer over 
the last several years. Respondents' references to the need 
for "balance" between ensuring appropriate treatmenr of pain 
and disciplining physicians who are inappropriately prescrib-
ing opioids are illustrar.ive of this movement. The work of a 
number of individuals and agencies, including the Wiscon-
sin Pain & Policy Studies Group, the American Society of 
Law, Medicine & Ethics, the Federation of State MedicaJ 
Boards, through its Model Guidelines, and the recent DEA 
joint statement, has reinforced this message of the need for 
baJance and may have played a role in moving boards for-
ward on this learning curve. Moreover, boards' abandonment 
of opioid quantity as a marker of questionable practice, in 
favor of an individual assessment of whether the physician 
has appropriately evaluated cl1e patient, prescribed consis-
tent with board guidelines, and appropriately documented 
his or her prescribing, further indicates progress in board 
recognition of the need for adequate pain rreatmenr. 
At the same time, some attitudes and practices by boards 
remain problematic- in particular, a continued tolerance 
of undertreatment. While many boards are becoming more 
proactive in educating physicians about pain management 
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issues, rhe focus is on what physicians who prescribe opio ids 
for pain must do ro avoid board scrutiny. There appears to be 
a discrepancy in the weight given to vio lation of standard of 
care, patient harm, and gross negligence for overprescribing 
as compared ro underprescribing. Ironically, boards seem ro 
have a higher thre!>hold for patient harm in cases invo lving 
pain undenreatmenr- particularly for chronic, nonmalig-
nant pain. To this extent, physicians may be getting mixed 
messages from boards: on the one hand, that effectively man-
aging tl1eir patients' pain is rhe expected standard of care; 
and on the other hand, tllat me board is more concerned 
about opio id overprescribing than underprescribi ng. Perhaps 
this is unavoidable given the realities of opioid diversion 
practices. ln terms of lessons one might rake away from these 
findings, reformers may have to accepr that management o f 
chronic pain inevitably carries with it a greater chance of 
enr:mglement with licensing and law enfo rcement aurhori -
ties than mamgemenr of cancer pain, given the higher risks 
of cliver!>ion. 
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